Evidence map›Paper›PMID 39702261›Full record

ArticleBMC women's health2024

A new subtype of papillary ductal carcinoma in situ with tall cell and reversed polarity morphology: a rare case report.

Ruiqi Zhong, Ziyi Chang, Xiuhong Wang, Dingrong Zhong

Abstract readCase Reports
In one paragraph

Article in BMC women's health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ruiqi Zhong *4+4 Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Ziyi Chang *Department of Pathology, China-Japan Friendship Hospital, No. 2, Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China.
Xiuhong WangDepartment of Pathology, China-Japan Friendship Hospital, No. 2, Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China. doc_wang2008@126.com.
Dingrong ZhongDepartment of Pathology, China-Japan Friendship Hospital, No. 2, Yinghuayuan East Street, Chaoyang District, Beijing, 100029, China. 748803069@qq.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccording to previous studies, tall cell carcinoma with reversed polarity can be easily distinguished from ductal carcinoma in situ based on the absence of myoepithelium and a typical histologic feature. However, to the best of our knowledge, no cases of papillary ductal carcinoma exhibiting tall cell and reversed polarity features with intact myoepithelium have been reported, and thus its diagnosis and prognosis remain unclear. CASE PRESENTATION: A 54-year-old female with a palpable lump in her right breast for 3 years. There were no other symptoms found. A preoperative ultrasound examination showed an oval, well-circumscribed, anechoic cystic appearance with hypoechoic adnexal nodules, classified as 3-4a in the Breast Imaging Reporting Data System. Surgical excision revealed an in-situ breast carcinoma exhibiting a solid papillary pattern and tall cell with reversed polarity of nuclei. After thorough postoperative pathology, immunohistochemistry, and next-generation sequencing, we hypothesized that it might be a new ductal carcinoma in situ subtype with tall cells and reversed polarity of the mammary gland.

conclusionsWe herein present a rare case of papillary ductal carcinoma in situ with tall cell and reversed polarity morphology breast cancer, which can closely mimic tall cell carcinoma with reversed polarity and ductal carcinoma in situ. Thorough evaluations of histologic features, immunohistochemistry results, and genetic alterations are significant in identifying this rare entity. In addition, this type of breast cancer is low-malignant and has a favorable prognosis without any adjuvant therapy after complete resection.

Indexed as

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingCarcinoma, PapillaryFemaleHumansMastectomySentinel Lymph Node BiopsyTreatment OutcomeUltrasonographyBreast cancerCase reportPapillary ductal carcinoma in situTall cell carcinoma with reversed polarityTriple-negative phenotype

Identifiers

PMID39702261
PMCPMC11658091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.